Pricing drugs, selling hype and how we got here in the first place
May 15, 2018 - 15:46
Radio and PodcastLive Radio & Podcasts
Science & Medicine
Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place
In an episode free of Valeant Pharmaceuticals and Martin Shkreli, Fierce editors discuss a Senate investigation into Gilead Sciences' pricing of the hepatitis C drug Sovaldi, BioMarin's efforts to win approval for a rare...
About This Episode
Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place is an episode from FierceBiotech Radio. In an episode free of Valeant Pharmaceuticals and Martin Shkreli, Fierce editors discuss a Senate investigation into...
Podcast
This episode belongs to FierceBiotech Radio.
Listen Online
Use the player on this page to stream the episode online.
Episode Details
Published Dec 3, 2015, 24:31 long, audio available.
Related Episodes
Continue listening to more episodes from FierceBiotech Radio.
Questions About This Episode
What is Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place about?
In an episode free of Valeant Pharmaceuticals and Martin Shkreli, Fierce editors discuss a Senate investigation into Gilead Sciences' pricing of the hepatitis C drug Sovaldi, BioMarin's efforts to win approval for a rare disease treatment and GlaxoSmithKline's latest woes in China.
Where can I listen to Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place?
You can listen to Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place online on Radio and Podcast. Open the player on this page to stream the available audio.
Which podcast is Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place from?
Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place is an episode from FierceBiotech Radio.
How long is this episode?
This episode is 24:31 long.
When was this episode published?
This episode was published on Dec 3, 2015.
Can I save Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place for later?
Yes. Use the heart button on the episode page to add it to your favorite episodes list.
Are there related episodes from FierceBiotech Radio?
Yes. This page shows related episodes from FierceBiotech Radio when more episodes are available from the podcast feed.
Quick Answers About This Episode
Where can I listen to Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place?
You can listen to Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place on this page when the episode audio is available from the podcast feed.
Which podcast is this episode from?
Gilead's maxed-out revenue, BioMarin's FDA struggles, and GSK's rock and hard place is from FierceBiotech Radio.
What are the episode details?
Published Dec 3, 2015 and 24:31 long